224 filings
Page 7 of 12
8-K
osd 3lgxcpcw
4 Mar 19
Entry into a Material Definitive Agreement
4:15pm
8-K
n6kezq9vv9xlb9
19 Feb 19
VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10
4:18pm
8-K
u47b0ttcwc0u
1 Feb 19
AV-101 Stimulates the Formation of New Brain Cells in Nonclinical Studies
12:00am
8-K
eekg9185e2abqqi6cs
15 Jan 19
VistaGen Therapeutics Appoints Pharmaceutical Industry Veteran, Ann Cunningham, to its Board of Directors
4:16pm
8-K
tj9p6b ck7xsmx6io
11 Jan 19
Regulation FD Disclosure
5:30pm
8-K/A
by12tyh
13 Dec 18
Unregistered Sales of Equity Securities
5:00pm
8-K
hwr b9gv2q
13 Nov 18
VistaGen Therapeutics Receives Notices of Allowance in Australia and Japan for AV-101 Patents Covering Treatment of Depression
12:00am
8-K
3w3 2jj3a4q9
30 Oct 18
VistaGen Therapeutics Reports Fiscal 2019 Second Quarter Financial Results
4:37pm
8-K
kx5liz1q91zhj9u
26 Oct 18
Entry into a Material Definitive Agreement
4:21pm
8-K
k9i38 azn
5 Oct 18
VistaGen Therapeutics Receives FDA Fast Track Designation for Development of AV-101 as a Non-Opioid Treatment for Neuropathic Pain
2:04pm
8-K
mtl 3eehl0xodwt1
18 Sep 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
8nyank uqofsv8jziz
13 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
ntoybt
14 Aug 18
Other Events
2:32pm
8-K
pvzq02v4s6zgffdos2
9 Aug 18
Unregistered Sales of Equity Securities
12:00am
8-K
rmg9s 9mxzdbkp4yh
27 Jun 18
VistaGen Therapeutics Reports Fiscal Year 2018 Financial Results and Provides Year-to-Date Highlights
2:09pm
8-K
6ogi4o7
13 Jun 18
VistaGen Therapeutics Issued Two Key U.S. Patents for Treatment of Depression with AV-101
12:00am
8-K
cqocxo0x5du ci5yi6
11 Jun 18
VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent for Use of Stem Cells to Treat Cancer and Autoimmune Disorders
4:05pm
8-K
fquuroe2llklybl
23 May 18
Other Events
4:15pm
8-K
kj3n5i
3 May 18
VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent regarding Methods of Production for AV-101
12:00am
8-K
1oij4684lo5f 1gnvz
10 Apr 18
VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101
12:00am